Please wait a moment . . .

 

Real-world service costs for neovascular-AMD clinics in the United Kingdom: Structured literature review and scenario analysis

November 14, 20240
nAMD Costs Zoe Design v7 (Flat)

Medialis Ltd  is proud to present our latest publication: “Real-world service cost’s for neovascular-AMD clinics in the United Kingdom: Structured literature review and scenario analysis” in Current Medical Research & Opinions Real-world Evidence section

 Key Highlights:

  •  Innovative Use of Neutral Theory & Jandhyala Method: We leveraged these advanced methodologies to develop the nAMD Service Non-Drug Cost Instrument (nAS), providing groundbreaking evidence for the inclusion of non-drug costs in cost-effectiveness assessments.
  • Comprehensive Analysis: Our study identified and analyzed 237 real-world non-drug service cost items, of which 217 met the consensus threshold and were included in the nAS.
  • Impact on Cost-Effectiveness Assessments: Findings revealed that current Health Technology Assessments (HTA) underestimate the true cost burden of UK NHS nAMD clinics. Our scenario analysis estimated annual per-patient clinic costs ranging from £845 to £13960, highlighting the substantial additional expenses due to operational strain.
  • Relevance to Policy & Practice: This research underscores the need to consider non-drug costs, particularly under strain conditions, in the cost-effectiveness evaluations of anti-VEGF treatments for nAMD. Durability and robustness of treatments emerge as crucial factors in these assessments.

Conclusion: The inclusion of non-drug costs in CEA is essential for a more accurate representation of the financial burden on healthcare services. This study marks a significant step towards more comprehensive and realistic economic evaluations in ophthalmology.

We would like to thank the authors for their valuable contribution to this work:

Sobha Sivaprasad, Clare Bailey, Louise Downey, Rose Gilbert, Richard Gale, Ajay Kotagiri, Sajjad Mahmood, Peter Morgan-Warren, Jackie Napier, Nirodhini Narendran, Ian Pearce, Christina Rennie, James Talks, Radek Wojcik, and Ravi Jandhyala.

Read the full article to explore our findings and methodology in detail: https://lnkd.in/d2-gjXba

For all your real-world evidence needs, get in touch with us at info@medialis.co.uk. Let’s advance healthcare economics together!

#HealthcareEconomics #Ophthalmology #CostEffectiveness #nAMD #NeutralTheory #JandhyalaMethod

 

Leave a Reply

Your email address will not be published. Required fields are marked *